« Meet Cheryl, alli user and pharmacist  | Main  | Millions of alli users are losing it »

Changes for alliconnect

In the marketing profession, change is a constant.  At alliconnect, we've recently had a change in leadership.

Founding alliconnect blogger, Steve Burton, recently resigned from his position as Vice President of Weight Control for GlaxoSmithKline Consumer Healthcare. Steve was instrumental to the creation of alliconnect blog and his blog entry on his oops experience is still one of the most visited posts to date. 

You will soon be introduced to Karen Scollick, the newly appointed Vice President for US Weight Control at GSK.  Karen has held many leadership positions in the GSK Consumer Healthcare business, the most recent as the General Manager for GSK Consumer Healthcare Canadian and Puerto Rico.

Look for her first post on alliconnect in the coming weeks.

Comments:

Does this mean the end of alliConnect or the transparency it has championed in speaking about life style changes and treatment effects?

Hi, this is Karen. Nothing is changing in the way we value openness and our honesty.

Transparency has worked well and consumers are responding.  alli is one of the top ten OTC drugs in the US.  It was also ranked one of Time Magazines Top Ten Medical Breakthroughs of 2007 and is currently the #1 pharmacy recommended weight loss medication.  

Transparency is important to our identity and it will to continue to be on alliconnect and throughout our communication.

I look forward to being able to share with you all the stories along the way as we do this...stay posted.

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.

 

   

 

Post

about this blog

  • alliConnect is GlaxoSmithKline's official corporate blog for alli, the only FDA-approved, OTC weight loss product. It's a place for you to have a conversation with us about weight loss issues. Because we work for a drug company we do have to abide by a few rules. Legal stuff...

Subscribe

  • RSS feed

    Enter your email address below to receive an email whenever a new entry is published.

comments policy

  • We want to hear from you! We review all comments in advance. Please stay on topic, be respectful of others' views and avoid profanity. More about our comments policy

Search this blog

Go

contact us

about gsk